🎗️ Risk of Malignancy Index (RMI, Adnexal Mass)
UseTriage adnexal masses and decide on gynecologic-oncology referral.
SourceJacobs I, et al. A risk of malignancy index for adnexal masses. BJOG 1990
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
≥ 200 warrants gynecologic-oncology referral.
When to use
Triage adnexal masses and decide on gynecologic-oncology referral.
How it works
RMI = ultrasound score U × menopausal status M × CA-125. RMI 1: U = 0/1/3, M = 1/3; RMI 2: U = 1/1/4, M = 1/4. ≥ 200 = elevated risk.
Key points
- ≥ 200 warrants gynecologic-oncology referral.
- Complementary to O-RADS imaging.
- RMI 1 is more specific, RMI 2 more sensitive.
References
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| RMI version | RMI 1 (U = 0/1/3, M = 1/3) |
|---|---|
| Number of ultrasound features (multilocular/solid/bilateral/ascites/intra-abdominal metastases) | 1 feature |
| Menopausal status | Premenopausal |
| Serum CA-125 | 80 U/mL |
→RMI80
- Calculation：U = 1 × M = 1 × CA-125 = 80 = 80 (RMI 1)
- Interpretation：RMI < 200: lower malignancy risk → correlate with imaging (e.g. O-RADS); follow up as needed
- Tip：Complementary to O-RADS imaging: RMI uses CA-125 + menopause + US features, O-RADS focuses on lesion morphology
| RMI version | RMI 1 (U = 0/1/3, M = 1/3) |
|---|---|
| Number of ultrasound features (multilocular/solid/bilateral/ascites/intra-abdominal metastases) | 0 features |
| Menopausal status | Premenopausal |
| Serum CA-125 | 80 U/mL |
→RMI0
- Calculation：U = 0 × M = 1 × CA-125 = 80 = 0 (RMI 1)
- Interpretation：RMI < 200: lower malignancy risk → correlate with imaging (e.g. O-RADS); follow up as needed
- Tip：Complementary to O-RADS imaging: RMI uses CA-125 + menopause + US features, O-RADS focuses on lesion morphology
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using Risk of Malignancy Index (RMI, Adnexal Mass)?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does Risk of Malignancy Index (RMI, Adnexal Mass) upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is Risk of Malignancy Index (RMI, Adnexal Mass) calculated in practice? Can you show a worked example?
- Inputs: RMI version RMI 1 (U = 0/1/3, M = 1/3), Number of ultrasound features (multilocular/solid/bilateral/ascites/intra-abdominal metastases) 1 feature, Menopausal status Premenopausal, Serum CA-125 80 U/mL → Result: RMI 80（Calculation: U = 1 × M = 1 × CA-125 = 80 = 80 (RMI 1), Interpretation: RMI < 200: lower malignancy risk → correlate with imaging (e.g. O-RADS); follow up as needed, Tip: Complementary to O-RADS imaging: RMI uses CA-125 + menopause + US features, O-RADS focuses on lesion morphology） Inputs: RMI version RMI 1 (U = 0/1/3, M = 1/3), Number of ultrasound features (multilocular/solid/bilateral/ascites/intra-abdominal metastases) 0 features, Menopausal status Premenopausal, Serum CA-125 80 U/mL → Result: RMI 0（Calculation: U = 0 × M = 1 × CA-125 = 80 = 0 (RMI 1), Interpretation: RMI < 200: lower malignancy risk → correlate with imaging (e.g. O-RADS); follow up as needed, Tip: Complementary to O-RADS imaging: RMI uses CA-125 + menopause + US features, O-RADS focuses on lesion morphology）